
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Lyell Immunopharma
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Using living cells to treat and sometimes even cure cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. At Lyell, our goal is to change that. We are a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for solid tumors based on our innovative technologies. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to defeat solid tumors, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage ...
C-Level 2 | VP - Level1 |
Director1 | Manager11 |
Others166 |
Structure | Email Format |
---|---|
<f><last>@ |
|
Pain Points | Locations | Technologies |
---|---|---|
Animation | South San Francisco, CA | network storage, compliance, disaster recovery, high availability, networking, workflow, data governance, infrastructure automation, k, scope, data center, cloud computing, windows, disaster, collaboration, video conferencing, infrastructure, sox, security, operations |
Application Development | Bothell, WA | communication, gmp, compliance, e, collaboration, change management, continuous improvement, cgmp, k, operations |
Application Development | San Francisco Bay Area | communication, integrity, compliance, e, collaboration, risk, data collection, data management, operations, k |
Application Development | South San Francisco, CA | media, network storage, compliance, disaster recovery, high availability, link, data analysis, troubleshooting, networking, procedure, workflow, communication, integrity, profiling, data governance, assessment, communication data, infrastructure automation, k, scope, data center, cloud computing, windows, disaster, collaboration, video conferencing, basic, infrastructure, sox, financial, e, risk, security, continuous improvement, operations |
Application Development | Washington, United States | communication, integrity, collaboration, risk, data collection, data management, operations, k |
Atlassian jira
Coldfusion
Gcp
Viewpoint
Access
Access management
Analytics
Assessment
Audit
Cgmp
Using living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances...
View MoreUsing living cells to treat and sometimes even cure cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. At Lyell, our goal is to change that. We are a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for solid tumors based on our innovative technologies. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and...
Lyell immunopharma operates in the Biotechnology research industry.
Lyell immunopharma's revenue is < 1m
Lyell immunopharma has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.